The advertisement promotes TRODELVY, highlighting its status as the first FDA-approved Trop-2-directed antibody-drug conjugate, while also providing important safety information and warnings regarding potential severe side effects.
Creative Information
| CID: | a112b925-f112-4efd-8d64-51e8630711c7 |
| CRID: | 89_269867 |
| Domain: | gilead.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $3.01 |
| Timestamp: | 2/2/2026, 2:58:51 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 2/2/2026, 2:59:20 AM | 4.01s | |
| adomain_analysis | success | 2/2/2026, 2:59:20 AM | 2.95s | |
| adomain_capture | success | 2/2/2026, 2:59:17 AM | 0.09s | |
| ad_render | success | 2/2/2026, 2:59:16 AM | 24.41s | |
| brand_mapping | success | 2/2/2026, 2:58:51 AM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Gilead
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 2130.83 KB | ||||||||||||||||||||||
| Render Time: | 9.55 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 2130.91 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

